ATE453623T1 - Synthese von dipeptidanaloga - Google Patents

Synthese von dipeptidanaloga

Info

Publication number
ATE453623T1
ATE453623T1 AT04818314T AT04818314T ATE453623T1 AT E453623 T1 ATE453623 T1 AT E453623T1 AT 04818314 T AT04818314 T AT 04818314T AT 04818314 T AT04818314 T AT 04818314T AT E453623 T1 ATE453623 T1 AT E453623T1
Authority
AT
Austria
Prior art keywords
synthesis
dipeptide analogues
dipeptide
analogues
processes
Prior art date
Application number
AT04818314T
Other languages
English (en)
Inventor
C A Busacca
N Haddad
S R Kapadia
Keenan L Smith
J C Lorenz
C H Senanayake
X Wei
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE453623T1 publication Critical patent/ATE453623T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04818314T 2003-10-30 2004-10-27 Synthese von dipeptidanaloga ATE453623T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51584803P 2003-10-30 2003-10-30
PCT/US2004/035833 WO2005044799A1 (en) 2003-10-30 2004-10-27 Dipeptide-analogue synthesis

Publications (1)

Publication Number Publication Date
ATE453623T1 true ATE453623T1 (de) 2010-01-15

Family

ID=34572859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04818314T ATE453623T1 (de) 2003-10-30 2004-10-27 Synthese von dipeptidanaloga

Country Status (7)

Country Link
US (1) US7186827B2 (de)
EP (1) EP1682506B1 (de)
JP (1) JP2007509961A (de)
AT (1) ATE453623T1 (de)
CA (1) CA2543884A1 (de)
DE (1) DE602004024916D1 (de)
WO (1) WO2005044799A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668870A1 (de) 1991-06-14 1995-08-30 Chiron Corporation Inhibitoren der picornavirus-protease
US5804560A (en) 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
NZ503889A (en) 1997-11-05 2002-07-26 Novartis Ag Dipeptide nitriles
GB9723407D0 (en) 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US7326719B2 (en) * 2003-03-13 2008-02-05 Boehringer Ingelheim Pharmaceuticals, Inc. Cathepsin S inhibitors

Also Published As

Publication number Publication date
US20050113572A1 (en) 2005-05-26
DE602004024916D1 (de) 2010-02-11
US7186827B2 (en) 2007-03-06
CA2543884A1 (en) 2005-05-19
EP1682506B1 (de) 2009-12-30
WO2005044799A1 (en) 2005-05-19
EP1682506A1 (de) 2006-07-26
JP2007509961A (ja) 2007-04-19

Similar Documents

Publication Publication Date Title
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
SE0403171D0 (sv) New compounds
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
DE60313173D1 (de) Synthese von purin-derivaten
DE602004029355D1 (de) Sulfopyrrolderivate
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
MXPA05010398A (es) Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril.
CY1111081T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγκομελατινης
CY1107101T1 (el) Μεθοδος συνθεσης παραγωγων της 1,3-διϋδρο-2h-3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης με φαρμακευτικως αποδεκτο οξυ
GB0327323D0 (en) Novel pharmaceuticals
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
NO20063293L (no) Farmasoytiske forbindelser
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
ATE453623T1 (de) Synthese von dipeptidanaloga
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
GEP20084370B (en) Synthesis of perindopril and the pharmaceutically-acceptable salts thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties